Nanodiagnostics
Nanoscale diagnostic tools and biosensors for disease detection
Nanosphere (Luminex)
Northbrook, United States
Developer of molecular diagnostics platform using gold nanoparticle probe technology for rapid disease detection
NanoString Technologies
Seattle, United States
Life sciences company developing tools for gene expression analysis using nanoparticle-based molecular barcoding technology
nanoComposix
San Diego, United States
Designer and manufacturer of precisely engineered nanoparticles for diagnostics and research
Harris & Harris Group
New York, United States
Venture capital firm focused on nanotechnology and transformative companies
Lux Capital
New York, United States
Venture capital firm investing in deep technology including nanotechnology
Arch Venture Partners
Chicago, United States
Venture capital firm focusing on early-stage technology companies including nanotech
NanoXact
San Diego, United States
Brand offering precisely manufactured nanoparticles for life science applications
Exosome Diagnostics
Waltham, United States
Exosome Diagnostics, founded in 2008 in Waltham, Massachusetts, emerged as a global leader in exosome-based liquid biopsy technology before being acquired by Bio-Techne Corporation. The company pioneered the use of exosomes—nanoscale extracellular vesicles (30-150 nm) naturally released by cells—as biomarkers for non-invasive disease detection and monitoring. Exosomes contain genetic material, proteins, and other molecular cargo that reflect the state of their cell of origin, making them valuable diagnostic tools for cancer and other diseases. Exosome Diagnostics developed sophisticated isolation and analysis technologies to capture these nanovesicles from bodily fluids and extract clinically relevant biomarkers, particularly RNA and DNA molecules. The company's flagship product, the ExoDx Prostate Test (IntelliScore), represents a breakthrough in prostate cancer detection, analyzing exosomal RNA from urine samples to help determine the need for prostate biopsy, thereby reducing unnecessary invasive procedures. This non-invasive approach leverages the natural biology of exosomes, which are shed into circulation and easily accessible through liquid biopsies. Exosome Diagnostics also developed comprehensive exosome isolation kits enabling researchers and clinicians to harness these nanosized vesicles for biomarker discovery and diagnostic applications. The company raised over $100 million in funding and established strategic partnerships with pharmaceutical companies and research institutions. The acquisition by Bio-Techne expanded the reach of exosome diagnostics technology within a larger life sciences organization. Exosome-based diagnostics represent a paradigm shift from traditional tissue biopsies to liquid biopsies, offering less invasive, repeatable testing that can track disease progression and treatment response. As precision medicine advances, exosome diagnostics continues to play a crucial role in enabling earlier disease detection, personalized treatment selection, and real-time monitoring, establishing exosomes as a transformative platform in nano-diagnostics and molecular medicine.
Nanomix
Emeryville, United States
Nanomix, established in 2000 in Emeryville, California, is a pioneering company in nanosensor technology, specializing in carbon nanotube-based electronic biosensors for point-of-care medical diagnostics. The company has raised over $75 million in funding to develop its innovative diagnostic platform that leverages the exceptional electronic and chemical properties of carbon nanotubes for rapid, accurate medical testing. Carbon nanotubes, cylindrical nanostructures with diameters of just a few nanometers, exhibit extraordinary sensitivity to surface chemical changes, making them ideal transducers for biosensing applications. Nanomix's proprietary technology functionalizes carbon nanotubes with specific recognition molecules that bind target biomarkers, causing measurable changes in the nanotubes' electrical conductivity. This direct electronic detection mechanism enables rapid, label-free measurement of clinically relevant analytes. The company's flagship eLab diagnostic system brings laboratory-quality testing to the point of care, providing rapid results for critical biomarkers directly at the patient's bedside, in emergency departments, or in physician offices. The system can measure multiple analytes including blood gases, electrolytes, and metabolites from small blood samples, with results available in minutes rather than the hours typically required for central laboratory testing. This speed enables faster clinical decision-making, particularly critical in acute care settings. The nanosensor technology offers significant advantages including small sample volumes, minimal reagent consumption, and the potential for highly multiplexed testing. Nanomix's platform addresses the growing demand for decentralized diagnostic testing, aligning with trends toward personalized medicine and value-based healthcare. The company's work exemplifies how nanotechnology can transform medical diagnostics, bringing sophisticated analytical capabilities out of centralized laboratories and directly to patients. As point-of-care testing continues to expand globally, Nanomix's carbon nanotube-based sensors represent a significant technological advancement in making rapid, accurate diagnostic information immediately available to healthcare providers.
Nanobix
Basel, Switzerland
Nanobix, founded in 2018 in Basel, Switzerland, is an innovative biotechnology company developing next-generation nanopore-based biosensors for rapid point-of-care diagnostics. Based in Basel, a global hub for pharmaceutical and biotechnology innovation, Nanobix leverages cutting-edge nanotechnology to create diagnostic devices that can detect disease biomarkers quickly and accurately outside traditional laboratory settings. The company's nanopore biosensor platform utilizes nanoscale pores—typically 1-10 nanometers in diameter—embedded in thin membranes as highly sensitive molecular detectors. When target molecules pass through or interact with these nanopores under an applied electrical field, they produce characteristic changes in ionic current that serve as molecular fingerprints for identification and quantification. This single-molecule detection approach offers exceptional sensitivity and specificity, enabling detection of biomarkers at clinically relevant concentrations from small sample volumes. Nanobix's technology addresses critical needs in point-of-care diagnostics, where rapid results can significantly impact patient management and treatment decisions. The nanopore platform is particularly well-suited for detecting nucleic acids, proteins, and other biomolecules associated with infectious diseases, cancer, and cardiovascular conditions. Unlike conventional diagnostic methods requiring extensive sample preparation and laboratory infrastructure, nanopore sensors can potentially deliver results in minutes from raw or minimally processed samples. The company has secured over $5 million in funding to advance its platform through development and validation stages. Switzerland's strong scientific ecosystem, with world-class universities and research institutions, provides Nanobix with access to expertise in nanofabrication, biosensor development, and clinical diagnostics. The company's work represents an important advancement in translating nanopore technology, originally developed for DNA sequencing, into broader diagnostic applications. As healthcare systems increasingly emphasize decentralized testing and rapid diagnosis, Nanobix's nanopore biosensors could play a significant role in bringing laboratory-quality diagnostics to point-of-care settings worldwide.
Naneum Ltd
Canterbury, United Kingdom
UK company developing portable nanoparticle analysis instruments
NanoString Technologies
Seattle, United States
Developer of molecular barcoding technology for gene expression analysis
Crystalplex
Pittsburgh, United States
Producer of quantum dots for biomedical imaging
Nanowear
New York, United States
Developer of nanosensor-enabled smart garments for health monitoring
Nano-Bio-MEMS
Cincinnati, United States
Developer of MEMS-based nanobiosensors
Nanosphere Biosciences
Boulder, United States
Developer of nanobubble-based therapeutic delivery systems
Singular Genomics
La Jolla, United States
Next-gen sequencing platform with nanoscale engineering
NanoScent
Haifa, Israel
AI-powered nano-sensor platform for scent detection
NanoEnTek
Seoul, South Korea
Lab-on-a-chip and cell analysis systems
Nanox Imaging
Neve Ilan, Israel
Digital x-ray source using nanotechnology
Mintek
Johannesburg, South Africa
Minerals research with nanotechnology programs
T2 Biosystems
Lexington, United States
Magnetic nanoparticle-based diagnostics
Nanoimmunotech
A Coruña, Spain
Immunomagnetic nanoparticles for diagnostics
Nanoparticle Dream
Tokyo, Japan
Quantum dot nanoparticles for biomedical imaging and diagnostics
NH TherAguix
Villeurbanne, France
Gadolinium-based nanoparticles for MRI-guided radiotherapy
Takeda Pharmaceutical
Tokyo, Japan
Global pharma with nanomedicine programs
Astellas Pharma
Tokyo, Japan
Major pharma with nanotechnology drug delivery research
Shionogi & Co.
Osaka, Japan
Infectious disease pharma with nanoparticle research
Sumitomo Pharma
Osaka, Japan
Regenerative medicine and nanomedicine programs
Yuhan Corporation
Seoul, South Korea
Korean pharma with nanoformulation programs
Daewoong Pharmaceutical
Seoul, South Korea
Innovative drug delivery and biologics
CSPC Pharmaceutical
Shijiazhuang, China
Major Chinese pharma with nanomedicine research
WuXi AppTec
Shanghai, China
Global CRO/CDMO with nanomedicine manufacturing capabilities
Attomol
Bronkow, Germany
Nanoparticle-based diagnostic systems
Nano4Imaging
Düsseldorf, Germany
Iron oxide nanoparticles for MRI contrast agents
University of São Paulo Nanomedicine
São Paulo, Brazil
Nanomedicine research at South America's largest university
Exiqon
Vedbaek, Denmark
Locked nucleic acid technology for RNA research and diagnostics
Abbott Laboratories
Abbott Park, United States
Healthcare company with nanotechnology-based diagnostics and glucose monitoring
Dexcom
San Diego, United States
Continuous glucose monitoring using advanced nanosensor technology
Senseonics
Germantown, United States
Implantable continuous glucose monitoring with fluorescent nanosensor technology
BioVision
Milpitas, United States
Life science reagents including nanoparticle-based assays and detection kits
Creative Diagnostics
Shirley, United States
Diagnostic reagents including gold and magnetic nanoparticles for lateral flow assays
Cytodiagnostics
Burlington, Canada
Gold nanoparticles and conjugates for lateral flow and diagnostic applications
nanoComposix
San Diego, United States
Engineered nanoparticles for biomedical, diagnostic, and research applications
Ocean NanoTech
San Diego, United States
Quantum dots, iron oxide, and magnetic nanoparticles for biomedical research
Nanocs
New York, United States
PEGylation reagents and functionalized nanoparticles for biomedical applications
Spherotech
Lake Forest, United States
Microspheres and nanoparticles for flow cytometry, diagnostics, and research
Bangs Laboratories
Fishers, United States
Microspheres and polymer beads for diagnostics and flow cytometry
Miltenyi Biotec
Bergisch Gladbach, Germany
Magnetic cell separation using superparamagnetic nanoparticles
Beckman Coulter Diagnostics
Brea, United States
Clinical diagnostics with nanoparticle-based immunoassays and flow cytometry
Siemens Healthineers
Erlangen, Germany
Medical diagnostics with nanotechnology-based immunoassays and imaging agents
Roche Diagnostics
Basel, Switzerland
Clinical diagnostics leader with nanoparticle-enhanced immunoassays
Bio-Techne
Minneapolis, United States
Life science tools including nanoparticle-based reagents and spatial biology
PerkinElmer
Waltham, United States
Analytical instruments and diagnostics with nanoparticle-based assay technologies
Cepheid
Sunnyvale, United States
Molecular diagnostics with microfluidic cartridges and nanoscale detection
bioMérieux
Marcy-l'Étoile, France
In vitro diagnostics with nanoparticle-based detection technologies
Hologic
Marlborough, United States
Molecular diagnostics with advanced detection technologies for women's health
Exact Sciences
Madison, United States
Cancer screening using molecular diagnostic and nanoparticle detection technologies
Guardant Health
Redwood City, United States
Liquid biopsy for cancer detection using circulating tumor DNA analysis
GRAIL
Menlo Park, United States
Multi-cancer early detection using cell-free DNA and advanced sequencing
Foundation Medicine
Cambridge, United States
Comprehensive genomic profiling for cancer using advanced sequencing
Tempus
Chicago, United States
AI-driven precision medicine with genomic sequencing and diagnostics
Natera
Austin, United States
Cell-free DNA testing for prenatal screening and cancer detection
Invitae
San Francisco, United States
Genetic testing company with comprehensive hereditary cancer panels
Myriad Genetics
Salt Lake City, United States
Molecular diagnostics for hereditary cancer and prenatal screening
Color Health
Burlingame, United States
Population-scale genetic testing and COVID-19 testing infrastructure
BGI Genomics
Shenzhen, China
Genomics company with sequencing platforms and diagnostic services
Berry Genomics
Beijing, China
Non-invasive prenatal testing and genetic diagnostics in China
Annoroad Gene Technology
Beijing, China
Genomic sequencing services and bioinformatics solutions
Burning Rock Biotech
Guangzhou, China
Cancer genomics and liquid biopsy diagnostics company in China
Singlera Genomics
Shanghai, China
DNA methylation-based early cancer detection and liquid biopsy
Council of Scientific and Industrial Research
New Delhi, India
Indian network of research labs with extensive nanotechnology programs
UNICAMP Nanotechnology
Campinas, Brazil
Brazilian university with semiconductor and nanotechnology facilities
Hebrew University of Jerusalem Nano
Jerusalem, Israel
Major Israeli university with Center for Nanoscience and Nanotechnology
Hong Kong University of Science and Technology
Hong Kong, Hong Kong
Research university with Institute for Advanced Study nanomaterials focus
Chinese University of Hong Kong
Hong Kong, Hong Kong
Major university with Institute of NanoMaterials and NanoTechnology
Kyoto University Nano
Kyoto, Japan
Leading Japanese university with iCeMS nanobio research
Osaka University Nano
Osaka, Japan
Major Japanese university with SANKEN nanotechnology research
Seoul National University Nano
Seoul, South Korea
Korea's top university with Institute for Basic Science nanotech
NanoEnTek
Seoul, South Korea
Microfluidics and nano-scale diagnostic devices for life sciences
BBI Solutions
Cardiff, United Kingdom
Gold nanoparticles and reagents for in-vitro diagnostics
RainDance Technologies (Bio-Rad)
Billerica, United States
Droplet digital PCR technology, acquired by Bio-Rad
Sherlock Biosciences
Cambridge, United States
CRISPR-based molecular diagnostics platform
Intuitive Surgical
Sunnyvale, United States
Pioneer in robotic-assisted minimally invasive surgery with da Vinci systems
Abeona Therapeutics
New York, United States
Clinical-stage biopharmaceutical company developing gene therapies for rare diseases
Abbott Laboratories
Abbott Park, United States
Global healthcare company with diagnostics and medical device solutions
Becton Dickinson
Franklin Lakes, United States
Global medical technology company advancing the world of health
GE HealthCare
Chicago, United States
Medical technology company providing imaging, monitoring, and diagnostics solutions
Philips Healthcare
Amsterdam, Netherlands
Health technology company focused on improving health through innovation
Canon Medical Systems
Otawara, Japan
Medical imaging company developing CT, MRI, X-ray, and ultrasound systems
Varian Medical Systems
Palo Alto, United States
Medical device company focused on radiation oncology treatments
Elekta
Stockholm, Sweden
Medical technology company developing precision radiation medicine
Olympus Medical
Tokyo, Japan
Precision technology company with leading endoscopy and surgical solutions
Accuray
Sunnyvale, United States
Radiation oncology company developing precise cancer treatment systems
Resmed
San Diego, United States
Medical device company developing products for sleep apnea and respiratory care
Masimo
Irvine, United States
Medical technology company developing noninvasive patient monitoring solutions
iRhythm Technologies
San Francisco, United States
Digital healthcare company providing ambulatory cardiac monitoring services
Qiagen
Hilden, Germany
Provider of sample to insight solutions for molecular diagnostics
Veracyte
South San Francisco, United States
Genomic diagnostics company improving cancer diagnosis and treatment
CareDx
Brisbane, United States
Precision medicine company focused on transplant diagnostics
Adaptive Biotechnologies
Seattle, United States
Biotechnology company developing immune-driven medicine through sequencing
Senseonics Holdings
Germantown, United States
Medical technology company developing implantable continuous glucose monitoring
AngioDynamics
Latham, United States
Medical device company developing minimally invasive medical devices
Haemonetics
Boston, United States
Global healthcare company providing blood management solutions
Merit Medical
South Jordan, United States
Medical device company manufacturing products for interventional procedures
Natus Medical
Middleton, United States
Medical device company developing neurodiagnostic and newborn care solutions
Nanox
Neve Ilan, Israel
Medical imaging company developing novel digital X-ray source technology
Oscar Health
New York, United States
Technology-focused health insurance company with member-centric approach
Bright Health
Minneapolis, United States
Health insurance company partnering with care delivery systems
Devoted Health
Waltham, United States
Medicare Advantage plans with technology-driven care model
Alan
Paris, France
Digital health insurance company in Europe
Alan
Paris, France
Digital health insurance in Europe
LexisNexis Risk Solutions
Alpharetta, United States
Risk data and analytics for insurance
BIMA
Stockholm, Sweden
Mobile insurance for emerging markets
JustAnswer
San Francisco, United States
JustAnswer is an online platform connecting users with verified experts across multiple fields including legal, medical, veterinary, technical support, and automotive, providing on-demand answers and consultations for everyday questions and problems. Founded in 2003 in San Francisco with over $100 million in funding and 500+ employees, JustAnswer has facilitated millions of expert consultations, serving users in over 196 countries. The platform employs thousands of credentialed professionals including lawyers, doctors, veterinarians, mechanics, and technicians who provide personalized answers to user questions through a pay-per-question or subscription model. JustAnswer's legal category connects users with licensed attorneys who can provide guidance on family law, contracts, estate planning, employment disputes, and other legal matters at a fraction of traditional consultation costs. The medical experts offer health advice, symptom assessment, and second opinions, though they appropriately direct users to emergency services for urgent situations. Veterinary professionals help pet owners with animal health concerns, behavior issues, and treatment options. The platform's technical support experts assist with computer problems, software issues, and consumer electronics troubleshooting. JustAnswer's question-and-answer format allows users to describe their situation in detail, upload photos or documents, and engage in back-and-forth conversation until their question is fully answered. The platform verifies expert credentials, tracks customer satisfaction ratings, and maintains quality standards through monitoring and feedback systems. Users can browse previously answered questions, benefiting from the knowledge base built by millions of interactions. With 24/7 availability, multilingual support, and expertise across dozens of specialties, JustAnswer provides accessible, affordable expert guidance for everyday problems that might otherwise require expensive professional consultations.
Calibrate
New York, United States
Metabolic health company
Evident Technologies
Troy, United States
Quantum dot synthesis and applications
Nvigen
Sunnyvale, United States
Magnetic nanoparticle bioseparation
Ademtech
Pessac, France
Superparamagnetic beads for diagnostics
Nanosphere Inc
Northbrook, United States
Gold nanoparticle-based molecular diagnostics
Nanomix
Emeryville, United States
Carbon nanotube-based electronic biosensors
QDI Systems
Eindhoven, Netherlands
Quantum dots technology for X-ray imaging and mammography screening
Nanomedical Diagnostics
San Diego, United States
Graphene-based diagnostic platforms for accurate, timely health information
DNA Nanobots
Cambridge, United States
DNA-based nanodevices for targeted therapeutics delivery, vaccines, and diagnostics
NanoFCM
Nottingham, United Kingdom
Flow nano analyzer for high-resolution nanoparticle characterization
Nano4Tarmed
Coimbra, Portugal
Nanotechnology platforms for targeted medicine and cancer treatment
Bionano Genomics
San Diego, United States
Genome analysis tools using nanochannel technology
Poly-Dtech
Strasbourg, France
Fluorescent nanoparticle-based immunoassays and lateral flow tests for biomarker detection
Nostics
Amsterdam, Netherlands
AI-powered nanotechnology diagnostics for fast and accurate disease detection
Sona Nanotech
Halifax, Canada
Non-toxic gold nanorods for photothermal therapy and tumor-targeting drug delivery
Nanocare
Mumbai, India
Silver nanoparticle antimicrobial coatings for textiles and medical applications
HK Inno.N
Seoul, South Korea
Pharmaceutical nanotechnology for drug delivery systems
Diagnostic anSERS
College Park, United States
Handheld SERS-based detector for drugs and explosives identification
BioMagnetic Solutions
State College, United States
Magnetic nanoparticle solutions for bioseparation and diagnostics
Imagion Biosystems
Sydney, Australia
MagSense magnetic nanoparticle detection for cancer diagnostics
Micromod Partikeltechnologie
Rostock, Germany
Magnetic micro and nanoparticles for life science applications